BioMarin to Attend Three Investor Conferences in 1Q17
- Leerink Partners 6th Annual Global Healthcare Conference on February 16 in New York City
- Cowen and Company 37th Annual Health Care Conference on March 7 in Boston
- Barclays Global Healthcare Conference on March 15 in Miami
SAN RAFAEL, Calif., Feb. 8, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16, 2017 at 1:00pm ET, in New York City. Management will also participate in the Cowen and Company 37th Annual Health Care Conference on March 7, 2017 at 11:20am ET in Boston and the Barclays Global Healthcare Conference on March 15, 2017 at 8:00am ET, in Miami. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
Contacts: |
|
Investors |
Media |
Traci McCarty |
Debra Charlesworth |
BioMarin Pharmaceutical Inc. |
BioMarin Pharmaceutical Inc. |
(415) 455-7558 |
(415) 455-7451 |
SOURCE BioMarin Pharmaceutical Inc.
Share this article